MR

Manju Rajesh Gahoi

Active Director Director DIN 11071960
DIN 11071960 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Manju Rajesh Gahoi

Data last updated:

Manju Rajesh Gahoi is a Director at Abg Vivanta Biotech India Private Limited (since 2025).

DIN 11071960
Primary Designation Director
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Apr 20252025Active

Directorship timeline

Open interactive timeline →
Abg Vivanta Biotech India Private Limited
Premium access

Shareholding and investment profile for Manju Rajesh Gahoi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manju Rajesh Gahoi

Manju Rajesh Gahoi currently holds 1 directorship: Abg Vivanta Biotech India Private Limited (Director, since 24 Apr 2025).

Manju Rajesh Gahoi was first appointed on 24 Apr 2025 as Director at Abg Vivanta Biotech India Private Limited.

The current boards of Manju Rajesh Gahoi's companies include Azhar Mohd Shafi Kadri (Abg Vivanta Biotech India Private Limited), Beena Sharma (Abg Vivanta Biotech India Private Limited), Sailesh Ramnath Sharma (Abg Vivanta Biotech India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available